Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment

References

• Foucar K, Falini B, Stein H. Hairy cell leukaemia. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of hematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer (IARC); 2017. p. 226–228.
   Google Scholar
• Bouroncle BA, Wiseman BK, Doan CA. Leukemic Reticuloendotheliosis. Blood. 1958;8(7):609–630.
   Google Scholar
• Schrek R, Donnelly WJ. “Hairy” cells in blood in lymphoreticular neoplastic disease and “Flagellated” cells of normal lymph nodes. Blood. 1966;27(2):199–211.
   PubMed Web of Science ®Google Scholar
• Forbes SA, Beare D, Boutselakis H, et al. COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res. 2017;45(D1):D777–D783.
   PubMed Web of Science ®Google Scholar
• Teras LR, DeSantis CE, Cerhan JR, et al. US lymphoid malignancy statistics by world health organization subtypes. CA Cancer J Clin. 2016;66(6):443–459.
   PubMed Web of Science ®Google Scholar
• Gatta G, van der Zwan JM, Casali PG, et al. Rare cancers are not so rare: the rare cancer burden in Europe. Eur J Cancer. 2011;47(17):2493–2511.
   PubMed Web of Science ®Google Scholar
• Netherlands Cancer Registry (NCR) [Internet]. [place unknown]: IKNL. 2011 [cited 2018 Aug]. Available from http://www.cijfersoverkanker.nl.
   Google Scholar
• Patel K, Shah R, Parikh B, et al. Hairy cell leukemia: a clinicopathological study of 18 cases. Ann Pathol Lab Med. 2018;5(3):A256–A261.
   Google Scholar
• Barton JC, Edmunds HS Jr. Listeria monocytogenes infection in hairy cell leukemia: a case report and literature review. Case Rep Hematol. 2018;2018:5.
   Web of Science ®Google Scholar
• Roider T, Falini B, Dietrich S. Recent advances in understanding and managing hairy cell leukemia. F1000Res. 2018;7(F1000 Faculty Rev–509):9.
   PubMedGoogle Scholar
• Matutes E, Martínez-Trillos A, Campo E. Hairy cell leukaemia-variant: disease features and treatment. Best Pract Res Clin Haematol. 2015;28(4):253–263.
   PubMed Web of Science ®Google Scholar
• Robak T. Current treatment options in hairy cell leukemia and hairy cell leukemia variant. Cancer Treat Rev. 2006;32(5):365–376.
   PubMed Web of Science ®Google Scholar
• Letendre P, Doll D. Novel therapeutics in the treatment of hairy cell leukemia variant. Leuk Res. 2018;75:58–60.
   PubMed Web of Science ®Google Scholar
• Summers TA, Jaffe ES. Hairy cell leukemia diagnostic criteria and differential diagnosis. Leuk Lymphoma. 2001;52(sup2):6–10.
   Google Scholar
• Clavel J, Conso F, Limasset JC, et al. Hairy cell leukaemia and occupational exposure to benzene. Occup Environ Med. 1996;53(8):533–539.
   PubMed Web of Science ®Google Scholar
• Clavel J, Hémon D, Mandereau L, et al. Farming, pesticide use and hairy-cell leukemia. Scand J Work Environ Health. 1996;22(4):285–293.
   PubMed Web of Science ®Google Scholar
• Clavel J, Mandereau L, Conso F, et al. Occupational exposure to solvents and hairy cell leukaemia. Occup Environ Med. 1998;55(1):59–64.
   PubMed Web of Science ®Google Scholar
• Oleske D, Golomb HM, Farber MD, et al. A case-control inquiry into the etiology of hairy cell leukemia. Am J Epidemiol. 1985;121(5):675–683.
   PubMed Web of Science ®Google Scholar
• Nordström M, Hardell L, Magnuson A, et al. Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukaemia evaluated in a case-control study. Br J Cancer. 1997;77(11):2048–2052.
   Web of Science ®Google Scholar
• Nordström M, Hardell L, Lindström G, et al. Concentrations of organochlorines related to titers to epstein-barr virus early antigen IgG as risk factors for hairy cell leukemia. Environ Health Perspect. 2000;108(5):441–445.
   PubMed Web of Science ®Google Scholar
• Nordström M, Hardell L, Magnusson A, et al. Occupation and occupational exposure to UV light as risk factors for hairy cell leukaemia evaluated in a case-control study. Eur J Cancer Prev. 1997;6(5):467–472.
   PubMed Web of Science ®Google Scholar
• Monnereau A, Slager SL, Hughes AM, et al. Medical history, lifestyle, and occupational risk factors for hairy cell leukemia: the interlymph non-hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014(48):115–124.
   PubMedGoogle Scholar
• Clavel J, Mandereau L, Cordier S, et al. Hairy cell leukaemia, occupation, and smoking. Br J Haematol. 1995;91(1):154–161.
   PubMed Web of Science ®Google Scholar
• Stewart DJ, Keating MJ. Radiation exposure as a possible etiologic factor in hairy cell leukemia (Leukemic Reticuloendotheliosis). Cancer. 1980;46(7):1577–1580.
   PubMed Web of Science ®Google Scholar
• Tiacci E, Trifonov V, Schiavoni G, et al. BRAF mutations in hairy cell leukemia. N Engl J Med. 2011;364(24):2305–2315.
   PubMed Web of Science ®Google Scholar
• Mason EF, Brown RD, Szeto DP, et al. Detection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variant. Leuk Lymphoma. 2017;58(1):233–236.
   PubMed Web of Science ®Google Scholar
• Durham BH, Getta B, Dietrich S, et al. Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations. Blood. 2017;130(14):1644–1648.
   PubMed Web of Science ®Google Scholar
• Tiacci E, Pettirossi V, Schiavoni G, et al. Genomics of hairy cell leukemia. J Clin Oncol. 2017;35(9):1002–1010.
   PubMed Web of Science ®Google Scholar
• Villemagne B, Bay JO, Tournilhac O, et al. Two new cases of familial hairy cell leukemia associated with HLA haplotypes A2, B7, Bw4, Bw6. Leuk Lymphoma. 2005;46(2):243–245.
   PubMed Web of Science ®Google Scholar
• Seshadri RS, Brown EJ, Zipursky A. Leukemic Reticuloendotheliosis – A failure of monocyte production. N Engl J Med. 1976;295(4):181–184.
   PubMed Web of Science ®Google Scholar
• Espinouse D, Touraine JL, Schmitt D, et al. Specific anti-hairy cell and anti-B cell antisera: characterization of surface antigens and origin of hairy cells. Clin Exp Immunol. 1980;39(3):756–767.
   PubMed Web of Science ®Google Scholar
• Bethel KJ, Sharpe RW. Pathology of hairy-cell leukaemia. Best Pract Res Clin Haematol. 2003;16(1):15–31.
   PubMed Web of Science ®Google Scholar
• Zuzel M, Cawley JC. The biology of hairy cells. Best Pract Res Clin Haematol. 2003;16(1):1–13.
   PubMed Web of Science ®Google Scholar
• Williams T, Taute L, Dunlap J, et al. 188 A case of hairy cell leukemia uncharacteristically presents with absolute monocytosis as a manifestation of a concurrent myelodysplastic/myeloproliferative neoplasm. Am J Clin Pathol. 2018;149(suppl_1):S80.
   Google Scholar
• Hersh EM, Murphy S, Zander A, et al. Host defense deficiency in hairy cell leukemia and its correction by leukocyte transfusion. Blood. 1980;56(3):526–533.
   PubMed Web of Science ®Google Scholar
• Zhang X, Machii T, Matsumura I, et al. Constitutively activated rho guanosine triphosphatases regulate the growth and morphology of hairy cell leukemia cells. Int J Hematol. 2002;77(3):263–273.
   Web of Science ®Google Scholar
• Matallanas D, Birtwistle M, Romano D, et al. Raf family kinases: old dogs have learned new tricks. Genes Cancer. 2011;2(3):232–260.
   PubMedGoogle Scholar
• Barras D. BRAF mutation in colorectal cancer: an update. Biomark Cancer. 2015;7(S1):9–12.
   PubMedGoogle Scholar
• Falini B, Martelli MP, Tiacci E. BRAF-V600E mutation in hairy cell leukemia: from bench to bedside. Blood. 2016;128(15):1918–1927.
   PubMed Web of Science ®Google Scholar
• Dhillon S. Moxetumomab Pasudotox: first Global Approval. Drugs. 2018;78:1763–1767.
   PubMed Web of Science ®Google Scholar
• Turakhia S, Lanigan C, Hamadeh F, et al. Immunohistochemistry for BRAFV600E in the differential diagnosis of hairy cell leukemia vs other splenic B-cell lymphomas. Am J Clin Pathol. 2015;144:87–93.
   PubMed Web of Science ®Google Scholar
• Wierda WG, Byrd JC, Abramson JS, et al. Hairy cell leukemia, version 2.2018. J Natl Compr Canc Netw. 2017;15(11):1414–1427.
   PubMed Web of Science ®Google Scholar
• Golomb HM, Lindgren V, Rowley JD. Chromosome abnormalities in patients with hairy cell leukemia. Cancer. 1978;41(4):1374–1380.
   PubMed Web of Science ®Google Scholar
• Sadamori N, Han T, Kakati S, et al. Chromosomes and causation of human cancer and leukemia. LI. A hairy cell leukemia case with 14q+ and ring chromosomes: significance of ring chromosomes in blood disorders. Cancer Genet Cytogenet. 1983;10(1):67–77.
   PubMedGoogle Scholar
• Haglund U, Juliusson G, Stellan B, et al. Hairy cell leukemia is characterized by clonal chromosome abnormalities clustered to specific regions. Blood. 1994;83(9):2637–2645.
   PubMed Web of Science ®Google Scholar
• Sucak GT, Ogur G, Topal G, et al. del(17)(q25) in a patient with hairy cell leukemia: a new clonal chromosome abnormality. Cancer Genet Cytogenet. 1998;100(2):152–154.
   PubMedGoogle Scholar
• Sambani C, Trafalis DTP, Mitsoulis-Mentzikoff C, et al. Clonal chromosome rearrangements in hairy cell leukemia: personal experience and review of literature. Cancer Genet Cytogenet. 2001;129(2):138–144.
   PubMedGoogle Scholar
• Hammond DW, Hancock BW, Goyns MH. Analysis of 14q+ derivative chromosomes in non-hodgkin’s lymphomas by fluorescence in-situ hybridization. Leuk Lymphoma. 1995;20(1–2):111–117.
   PubMed Web of Science ®Google Scholar
• Ruiz-Garcia E, Matus-Santos JA, Guadarrama-Orozco JA, et al. Frequency of BRAFV600E mutation in the mexican population of patients with metastatic melanoma. J Glob Oncol. 2018;4(4):1–5.
   PubMedGoogle Scholar
• Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949–954.
   PubMed Web of Science ®Google Scholar
• Millington GWM. Mutations of the BRAF gene in human cancer, by Davies et al. (Nature 2002; 417;949-54). Clin Exp Dermatol. 2013;38(2):222–223.
   PubMed Web of Science ®Google Scholar
• Wan PTC, Garnett MJ, Roe SM, et al. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell. 2004;116(6):855–867.
   PubMed Web of Science ®Google Scholar
• Thevakumaran N, Lavoie H, Critton DA, et al. Crystal structure of a BRAF kinase domain monomer explains basis for allosteric regulation. Nat Struct Mol Biol. 2015;22(1):37–43.
   PubMed Web of Science ®Google Scholar
• Milne P, Bigley V, Bacon CM, et al. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood. 2017;130(2):167–175.
   PubMed Web of Science ®Google Scholar
• Tschernitz S, Flossbach L, Bonengel M, et al. Alternative BRAF mutations in BRAF V600E-negative hairy cell leukaemias. Br J Haematol. 2014;165(4):529–533.
   PubMed Web of Science ®Google Scholar
• Forconi F, Poretti G, Kwee I, et al. High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia. Br J Haematol. 2008;141(5):622–630.
   PubMed Web of Science ®Google Scholar
• Xi L, Arons E, Navarro W, et al. Both variant and IGHV4-34-expressing hairy cell leukemia lack the BRAF V600E mutation. Blood. 2012;119(14):3330–3332.
   PubMed Web of Science ®Google Scholar
• Hossain A, Rafei H, Jariwala A, et al. A rare breed: wild-type braf and ighv expression in a 29 year old lady with classical hairy cell leukemia. Leuk Res Rep. 2017;7:20–22.
   PubMedGoogle Scholar
• Blombery PA, Wong SQ, Hewitt CA, et al. Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders. Haematologica. 2012;97:780–783.
   PubMed Web of Science ®Google Scholar
• Schnittger S, Bacher U, Haferlach T, et al. Development and validation of a real-time quantification assay to detect and monitor BRAFV600E mutations in hairy cell leukemia. Blood. 2012;119(13):3151–3154.
   PubMed Web of Science ®Google Scholar
• Brown NA, Betz BL, Weigelin HC, et al. Evaluation of Allel-Specific PCR and immunohistochemistry for the detection of BRAF V600E mutations in hairy cell leukemia. Am J Clin Pathol. 2015;143:89–99.
   PubMed Web of Science ®Google Scholar
• Brown NA, Weigelin HC, Bailey N, et al. Requisite analytic and diagnostic performance characteristics for the clinical detection of BRAFV600E in hairy cell leukemia: a comparison of 2 allele-specific PCR assays. Appl Immunohistochem Mol Morphol. 2015;23:590–600.
   PubMedGoogle Scholar
• Lennerz JK, Klaus BM, Marienfeld RB, et al. Pyrosequencing of BRAF V600E in routine samples of Hairy Cell Leukaemia identifies CD5+ variant Hairy Cell Leukemia that lacks V600E. Br J Haematol. 2012;157:267–269.
   PubMed Web of Science ®Google Scholar
• Langabeer SE, O’Brien D, Liptrot S, et al. Correlation of the BRAF V600E mutation in hairy cell leukaemia with morphology, cytochemistry and immunophenotype. Int JLab Haematol. 2012;34:417–421.
   PubMed Web of Science ®Google Scholar
• Michaloglou C, Vredeveld LCW, Soengas MS, et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005;436(7051):720–724.
   PubMed Web of Science ®Google Scholar
• Wajapeyee N, Serra RW, Zhu X, et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008;132(3):363–374.
   PubMed Web of Science ®Google Scholar
• Kuilman T, Michaloglou C, Vredeveld LCW, et al. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008;133(6):1019–1031.
   PubMed Web of Science ®Google Scholar
• Yun UJ, Park SE, Jo YS, et al. DNA damage induces the IL-6/STAT3 signaling pathway, which has anti-senescence and growth-promoting functions in human tumors. Cancer Lett. 2012;323(2):155–160.
   PubMed Web of Science ®Google Scholar
• Yamagiwa Y, Meng F, Patel T. Interleukin-6 decreases senescence and increases telomerase activity in malignant human cholangiocytes. Life Sci. 2006;78(21):2494–2502.
   PubMed Web of Science ®Google Scholar
• Sebastian T, Johnson PF. RasV12-mediated down-regulation of CCAAT/enhancer binding protein β in immortalized fibroblasts requires loss of p19Arf and facilitates bypass of oncogene-induced senescence. Cancer Res. 2009;69(6):2588–2598.
   PubMed Web of Science ®Google Scholar
• Lowe SW, Cepero E, Evan G. Intrinsic tumor suppression. Nature. 2004;432(7015):307–315.
   PubMed Web of Science ®Google Scholar
• Serrano M, Lin AW, McCurrach ME, et al. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997;88(5):593–602.
   PubMed Web of Science ®Google Scholar
• Taylor J, Xiao W, Abdel-Wahab O. Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood. 2017;130(4):410–423.
   PubMed Web of Science ®Google Scholar
• Maitre E, Bertrand P, Maingonnat C, et al. New generation sequencing of targeted genes in the classical and the variant form of hairy cell leukemia highlights mutations in epigenetic regulation genes. Oncotarget. 2018;9(48):28866–28876.
   PubMedGoogle Scholar
• Dietrich S, Hüllein J, Lee SCW, et al. Recurrent CDKN1B (p27) mutations in hairy cell leukemia. Blood. 2015;126(8):1005–1008.
   PubMed Web of Science ®Google Scholar
• Nagel S, Ehrentraut S, Meyer C, et al. NFkB is activated by multiple mechanisms in hairy cell leukemia. Genes Chromosomes Cancer. 2015;54(7):418–432.
   PubMed Web of Science ®Google Scholar
• De Boer CJ, Kluin-Nelemans JC, Dreef E, et al. Involvement of the CCND1 gene in hairy cell leukemia. Ann Oncol. 1996;7(3):251–256.
   PubMed Web of Science ®Google Scholar
• König EA, Kusser WC, Day C, et al. p53 mutations in hairy cell leukemia. Leukemia. 2000;14(4):706–711.
   PubMed Web of Science ®Google Scholar
• Marcsek ZL, König EA. Accumulating mutations of p53 in colon tumor and hairy cell leukemia do not arise from methylation/deamination processes, but rather from nucleotide deletions and insertions. Biol Chem. 1998;379(4–5):545–547.
   PubMed Web of Science ®Google Scholar
• Capello D, Vitolo U, Pasqualucci L, et al. Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia. Blood. 2000;95(2):651–659.
   PubMed Web of Science ®Google Scholar
• King AC, Kabel CC, Pappacena JJ, et al. No loose ends: a review of the pharmacotherapy of hairy cell and hairy cell leukemia variant. Ann Pharmacother. 2019;53:11.
   Web of Science ®Google Scholar
• Hisada M, Chen BE, Jaffe ES, et al. Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study. J Natl Cancer Inst. 2007;99:215–222.
   PubMed Web of Science ®Google Scholar
• Flinn IW, Kopecky KJ, Foucar MK, et al. Long-term follow-up of remission duration, mortality, and second malignancies in hairy cell leukemia patients treated with pentostatin. Blood. 2000;96(9):2981–2986.
   PubMed Web of Science ®Google Scholar
• Dietrich S, Pircher A, Endris V, et al. BRAF inhibition in hairy cell leukemia with low-dose vemurafenib. Blood. 2016;127(23):2847–2855.
   PubMed Web of Science ®Google Scholar
• Vergote V, Dierickx D, Janssens A, et al. Rapid and complete hematological response of refractory hairy cell leukemia to the BRAF inhibitor dabrafenib. Ann Hematol. 2014;93:2087–2089.
   PubMed Web of Science ®Google Scholar
• Arons E, Suntum T, Stetler-Stevenson M, et al. VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy. Blood. 2009;114(21):4687–4695.
   PubMed Web of Science ®Google Scholar
• Jain D, Dorwal P, Gajendra S, et al. CD5 positive hairy cell leukemia: a rare case report with brief review of literature. Cytometry B Clin Cytom. 2016;90(5):467–472.
   PubMed Web of Science ®Google Scholar
• Vinante F, Tomei P, Zaza G, et al. Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. Exp Hematol Oncol. 2013;2(22):1–5.
   PubMedGoogle Scholar
• Mitsogianni M, Mitsimponas N, Crespo F, et al. Concomitant non-small cell lung cancer and hairy cell leukemia in a patient harboring BRAF-V600E mutation in both tissues: a case report. Case Rep Oncol. 2018;11(1):109–113.
   PubMed Web of Science ®Google Scholar
• Ghorbani-Aghbolaghi A, Lechpammer M, Ali SF, et al. An extremely rare case of concurrent BRAF V600E mutation driven hairy cell leukemia and melanoma: case report and review of literature. Autops Case Rep. 2017;7(3):13–19.
   PubMedGoogle Scholar
• Kitagwa Y, Brahmachary M, Tiacci E, et al. A microRNA signature specific for hairy cell leukemia and associated with modulation of the MAPK-JNK pathways. Leukemia. 2012;26(12):2564–2567.
   PubMed Web of Science ®Google Scholar
• Schwarzmeier JD, Hilgarth M, Nguyen ST, et al. Inadequate production of hematopoietic growth factors in hairy cell leukemia: up-regulation of interleukin 6 by recombinant IFN-α in Vitro. Cancer Res. 1996;56(20):4679–4685.
   PubMed Web of Science ®Google Scholar
• Global Cancer Observatory. All Cancers [Internet]. Lyon, France: International Agency for Research on Cancer; 2018. p. 2. [[cited 2018 Nov]]. Available from: http://gco.iarc.fr/today/fact-sheets-cancers
   Google Scholar